Faculty profile

Matthew Cheng

ResearcherInfectious DiseasesMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Matthew Cheng

Researcher

Infectious Diseases

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2024.
Principal investigator on 11 research grants (11 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bacteremia Randomized Controlled Trial Bloodstream Infection Staphylococcus Aureus Endocarditis Platform Trial Clinical Trial Oral Antibiotics

Latest papers

Evaluating the impact of a SIMPlified LaYered consent process on recruitment of potential participants to the Staphylococcus aureus Network Adaptive Platform trial: study protocol for a multicentre pragmatic nested randomised clinical trial (SIMPLY-SNAP trial)
BMJ Open · 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial
Clinical Infectious Diseases · 2024
Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial.
JAMA network open · 2022 · first author

All 5 publications

Latest funding

Treatment of Enterococcal Bacteremia Platform (TENT)
CIHR · 2026 · Principal investigator
$1,946,926
Staphylococcus aureus Network Adaptive Platform trial in Pediatrics and Youth (SNAP-PY), Canada
CIHR · 2024 · Principal investigator
$1,067,176
An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform
CIHR · 2024 · Principal investigator
$1,683,000

All 16 grants and awards

Treatment of Enterococcal Bacteremia Platform (TENT)

Principal investigatorCIHR2026Project Grant

Principal investigators: Lee, Todd C; Briggs, Simon; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Golchi, Shirin; Goodman, Anna L; Hasse, Barbara; Kuehl, Richard; Martin, Yonas; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Sligl, Wendy I; Somayaji, Ranjani; Speich, Benjamin; Tong, Steven; Walls, Genevieve

Keywords: Bacteremia; Bloodstream Infection; Endocarditis; Enterococcus; Platform Trial; Randomized Controlled Trial

$1,946,926

Staphylococcus aureus Network Adaptive Platform trial in Pediatrics and Youth (SNAP-PY), Canada

Principal investigatorCIHR2024Project Grant

Principal investigators: Papenburg, Jesse; Bowen, Asha C; Cheng, Matthew P; Lee, Todd C

Keywords: Adaptive Clinical Trial; Antibiotics; Bacteremia; Cefzolin; Clindamycin; Flucloxacillin; Pediatrics; Penicillin; Staphylococcus Aureas; Vancomycin

$1,067,176

An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform

Principal investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle

Keywords: Immunomodulation; Platform Trial; Pneumocystis; Pneumonia; Randomized Controlled Trial; Secondary Prophylaxis; Treatment

$1,683,000

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Principal investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawler, Patrick R; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Antithrombotic Therapy; Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$539,325

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

Principal investigatorCIHR2024Project Grant

Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia

$539,325

Co-creating knowledge translation tools to support the implementation of Pregnancy-adapted Early Response Systems in rural settings

Co-investigatorCIHR2024Planning and Dissemination Grant - Institute Community Support

Principal investigators: Malhamé, Isabelle; Finch, Robert A; D'Souza, Rohan D

Keywords: Eclampsia; Hemorrhage; Hypertension; Maternal Mortality; Sepsis; Severe Maternal Morbidity

$24,970

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Nominated PICIHR2024PRIZE:Pro. GR. - PA: The Bhagirath Singh Early Career Prize in Inf. and Immunity

Principal investigators: Cheng, Matthew P

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$25,000

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Nominated PICIHR2024Project Grant

Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$1,705,952

Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita

Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine

$5,222,039

Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita

Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine

$1,305,510

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Matthew Cheng

Research

Latest papers

Latest funding

Evaluating the impact of a SIMPlified LaYered consent process on recruitment of potential participants to the Staphylococcus aureus Network Adaptive Platform trial: study protocol for a multicentre pragmatic nested randomised clinical trial (SIMPLY-SNAP trial)

Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial

Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial.

Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic.

Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.

Frequent collaborators

Srinivas Murthy

Nick Daneman

Mohammad-Ali Jenabian

Ranjani Somayaji

Jennie Johnstone

Ruxandra Pinto

Keith Walley

Alexis Turgeon

Marina Klein

Marie-Josee Brouillette

Christos Tsoukas

Robert Fowler

Francois Lamontagne

Jean-Pierre Routy

Christos Tsoukas

Arthur Slutsky

Jean-Pierre Routy

Alexandra de Pokomandy

Mohammad-Ali Jenabian

Emily McDonald

Alice Tseng

Mohammad-Ali Jenabian

John Boyd

Jennifer Tsang